OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS

9 Months Ended

Sep. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

OTHER CONSOLIDATED FINANCIAL STATEMENT DETAILS

Composition of Certain Financial Statement Captions

Components of selected captions in the consolidated condensed balance sheets consisted of the following (in millions):



	September 30, 2019		December 31, 2018
Inventories
Raw materials	$	125.8	$	111.5
Work in process	148.6		144.8
Finished products	336.7		350.7
	$	611.1	$	607.0

At September 30, 2019 and December 31, 2018, $122.5 million and $106.5 million, respectively, of the Company's finished products inventories were held on consignment. During the three months ended June 30, 2019, the Company recorded a $46.2 million charge to "Cost of Sales," primarily comprised of the write off of inventory related to strategic decisions regarding its transcatheter aortic valve portfolio, including the decision to discontinue its CENTERA program. During the three months ended September 30, 2019, the Company recorded an additional $26.9 million charge to "Cost of Sales" resulting from refinements to its portfolio strategy, which consists mainly of an additional write off of inventory. This amount includes an out-of-period adjustment of $10.3 million. The Company determined that the out-of-period adjustment is not material to the three or nine months ended September 30, 2019 or to any prior periods.



	September 30, 2019		December 31, 2018
Accounts payable and accrued liabilities
Accounts payable	$	135.9	$	134.0
Employee compensation and withholdings	262.2		226.1
Taxes payable (Note 14)	18.9		31.3
Property, payroll, and other taxes	43.2		39.5
Research and development accruals	61.2		48.9
Accrued rebates	78.0		80.0
Fair value of derivatives	4.5		4.4
Accrued marketing expenses	14.7		22.3
Litigation and insurance reserves	18.9		196.7
Accrued relocation costs	16.7		11.3
Accrued professional services	12.2		11.0
Accrued realignment reserves	16.4		6.8
Other accrued liabilities	68.9		64.3
	$	751.7	$	876.6

Supplemental Cash Flow Information

(in millions)



	Nine Months Ended September 30,
	2019		2018
Cash paid during the year for:
Income taxes	$	53.9	$	227.3
Amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	19.5	$	—
Non-cash investing and financing transactions:
Fair value of shares issued in payment for contingent consideration liabilities	$	—	$	34.3
Right-of-use assets obtained in exchange for new lease liabilities	$	33.2	$	—
Capital expenditures accruals	$	26.4	$	23.7